Similarly, in human kidney cancer patients, stem-like CD8 + T cells reside near MHC-II-expressing cells, and the population of stem-like CD8 + MHC-II complex could suggest a clinical benefit of immunotherapy40. The gene discussed is CD8A; the disease is kidney cancer.